A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia
Status:
Completed
Trial end date:
2012-06-25
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of intravenous (IV)
ferumoxytol compared to IV iron sucrose for the treatment of iron deficiency anemia (IDA).
Phase:
Phase 3
Details
Lead Sponsor:
AMAG Pharmaceuticals, Inc.
Treatments:
Ferric Compounds Ferric Oxide, Saccharated Ferrosoferric Oxide Iron